The First Malaria Vaccine to Meet the World Health Organization's Target of 75% Efficacy

Oxford team developed COVID vaccine with AstraZeneca on the strength of malaria research. When trialled in 450 children in Burkina Faso, the vaccine was found to be safe and showed high level efficacy over 12 months of follow-up. Larger trials in nearly 5,000 children between the ages of five months and three years will now be carried out across four African countries. World Health Organization estimates there were 229 million cases of worldwide malaria in 2019 and 409,000 deaths.